期刊文献+

高催乳素血症的药物治疗进展 被引量:4

下载PDF
导出
摘要 高催乳素血症(hyperprolactinemia, HPRLM)是由多种原因引起的以血清催乳素升高为主要表现的内分泌疾病,其治疗目前仍是以溴隐停为主的药物治疗加手术及放疗,近几年出现几种新的治疗药物。Cabergoline为一种较长效的特异性多巴胺受体激动剂,其在治疗HPRLM及生理性抑乳方面有较好的疗效。Quinagoline是一种非麦角碱多巴胺受体激动剂,可用于对麦角碱类药物过敏者及耐药者,促排卵药物及HRT也可用于HPRLM的辅助治疗。
出处 《现代妇产科进展》 CSCD 2000年第4期299-300,共2页 Progress in Obstetrics and Gynecology
  • 相关文献

参考文献14

  • 11,Mary LV,William S,Enans, et al. Bromocriptine. Annal Internal Med, 1984,100:78
  • 22,Katz E,Weiiss BE, Hassell A, et al. Increasesd circulating levels of bromocriptione after vaginal compared to oral administration. Fertil Steril, 1991,55:882
  • 33,Lengyel AM, Mussio W, lamamura P, et al.Long-acting injectiable bromocriptine(Parlodel LAR) in the chronic treatmemt of prolactin-secreting macroadenomas. Fertil Steril, 1993,59(5):980
  • 44,Rains CP, Bryson HM, Fitton A. Cabergoline. A review of its pharmacological properties and therapeutic potential in the treatment of hyperprolactinemia and inhibjition of laction.Drugs, 1995,49(2):225
  • 55,Ferrari C,Piscitell G, Crosignani PG. Cabergoline:A new drug for rhe treatment of hyperprolactinaemia. Hum Rrprod, 1995,10(7):1647
  • 66,Webster J. A comparative rveiew of the tolerability profiles of dopamine agonists in the trealment of hyerprolactinaenia and inhivition of lactation. Drug Saf,1996,14(4):228
  • 77,Kletzky OA, Marrs RP, Davijanv. Management of patients with hyperprolactinemia and normal or abnormal tomograms. Am J Obstet Gynecol, 1983, 147,528
  • 88,Parra A, Crespo G, Clinical and hormonal response to short-term intermitermittent versus continuous oral bromocriptine in hyerprolactinaemic women. J Fertil Menopausal Stud, 19995,40(2):96
  • 99,Hiraharf, Andon, Kaori Sawaik. Hypreprolactinemic recirrent miscarriage and results of fandomized bromociptine treatment triale. Fertil Steril, 1998,70(2):246
  • 1010,Reber PM. Prolactin and immunomodulation. Am J Med, 1995,172:63

同被引文献34

引证文献4

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部